On Category 2 with no current PCAC pathway
yet stock is weak HOOD +0.78%Yesterday, 6:10 PM Sempra to extend ECA LNG Phase 1 commissioning after finding compressor damage SRE -1.86%Yesterday, 6:06 PM1 Comment Here are the major earnings before the open Tuesday CMS -0.58%Yesterday, 6:00 PM1 Comment MaxLinear retreats another 9% as post-earnings bloodbath continues MXL -9.40%Yesterday, 5:48 PM6 Comments Blue Gold receives Nasdaq notice over minimum public float value requirement BGL +2.21%Yesterday, 5:45 PM Curium in talks to buy Lantheus Holdings for about $7B - Bloomberg LNTH +3.06%Yesterday, 5:37 PM1 Comment Banco Latinoamericano GAAP EPS of $1.77, revenue of $98.9M beats by $9.9M BLX -0.34%Yesterday, 5:32 PM Chinas gold stockpile could surpass U.S

Additionally, research published in Drug Testing and Analysis characterizing AOD9604 metabolism and confirming its C-terminal HGH fragment structure, supporting its classification as a non-IGF-1-stimulating lipolytic agent has been used by clinicians evaluating the compound for metabolic applications
Society for Neuroscience Abstracts
Closed rhinoplasty: The incisions are made within the nostrils, leaving no visible scarring and requiring a shorter recovery period
L., Medvedeva, Y